Kuala Lipis Hospital, Pahang, Malaysia.
Sultan Haji Ahmad Shah Hospital, Pahang, Malaysia.
Value Health Reg Issues. 2020 May;21:245-251. doi: 10.1016/j.vhri.2019.12.002. Epub 2020 Apr 27.
To calculate the total revenue under a hypothetical 1 Malaysian Ringgit (MYR) prescription cost sharing model in government healthcare facilities in Pahang, Malaysia.
A cross-sectional study was conducted at outpatient pharmacy in all government healthcare facilities in Pahang from year 2013 to 2017. Each dispensed medication was calculated as 1 MYR and contributed to the total revenue.
A total of 11 hospitals and 81 health clinics were recruited into the study. A hospital could generate 0.311 million MYR per year, and a district health department could generate 0.623 million MYR per year, giving a total of 10.268 million MYR revenue every year in Pahang, Malaysia. Under the prescription medicines cost sharing scheme, it was shown that an average of 9.4% of the total pharmaceutical spending could be recovered. The recovery percentage was approximately fourfold higher in health clinics (16.5%-21.7%) when compared with that in hospitals (4.3%-5.2%).
An estimated 10 million MYR or 10% from the total Ministry of Health pharmaceutical spending could be collected under the proposed 1 MYR prescription cost sharing model.
计算马来西亚彭亨州政府医疗机构实行 1 林吉特（MYR）处方费用共付假设模型下的总收入。
在 2013 年至 2017 年期间，对彭亨州所有政府医疗机构的门诊药房进行了横断面研究。将每种配药都算作 1 林吉特，计入总收入。
共招募了 11 家医院和 81 家卫生诊所参与研究。一家医院每年可产生 31.1 万林吉特的收入，一个地区卫生部门每年可产生 62.3 万林吉特的收入，马来西亚彭亨州每年的总收入为 1026.8 万林吉特。在处方药品费用分担计划下，显示可收回的药品总支出的平均比例为 9.4%。与医院（4.3%-5.2%）相比，卫生诊所的回收率（16.5%-21.7%）约高四倍。
根据拟议的 1 林吉特处方费用分担模式，估计可从卫生部药品总支出中收取 1000 万林吉特或 10%的费用。
